MD&E is performing site characterization activities and developing and stewarding closure strategies for a site in southwestern Michigan with soil and groundwater impacts comprised of chlorinated solvents, including PCE, TCE and carbon tetrachloride. A multi-national pharmaceutical company acquired the property through a corporate acquisition and is proactively addressing the site consistent with Part 201 of the Michigan Natural Resources and Environmental Protection Act, PA 451 of 1994, as amended. MD&E has been contracted to pursue a closure strategy that emphasizes compliance with due care responsibilities and low-cost management of off-site residual impacts.